Fulgent Genetics, Inc. (FLGT) - Rasio cepet

The visualized price action of Fulgent Genetics, Inc. (FLGT) demonstrates the current 6.15 coefficient. Fulgent Genetics, Inc. (FLGT) minimizes financial risks through a broad spectrum of genetic and oncology tests. Despite stagnant demand in the sector, the company is increasing order volumes through partnerships with pharma behemoths. Operational stability is ensured by modern software and the rapid updating of diagnostic methodologies across its US centers.

This indicator determines the ability of Fulgent Genetics, Inc. (FLGT) to instantaneously settle short-term liabilities using exclusively cash and accounts receivable, excluding illiquid inventories. An analysis of the quick ratio confirms an excess liquidity reserve for Fulgent Genetics, Inc. (FLGT), which, combined with a lack of debt burden and the efficiency of its AI diagnostic stack, guarantees exceptional financial stability and a steady free cash flow.